MFUS - ETF AI Analysis
Top Page
PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF (MFUS)
MFUS, the PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF, earns a solid overall rating thanks to strong core holdings like Apple, Johnson & Johnson, Walmart, and Merck, which combine robust financial performance, growth potential, and generally positive technical trends. The fund is somewhat held back by names such as Intel and AbbVie, where valuation and profitability concerns are more pronounced, and by holdings like Chevron and AT&T that show bearish momentum or higher debt levels. The main risk factor is its exposure to several large, mature companies facing cash flow, leverage, or momentum challenges, which could weigh on future returns if those issues persist.
MFUS vs. SPDR S&P 500 ETF (SPY)
- AUM
- 307.92M
- Region
- North America
- Expense Ratio
- 0.29%
- Beta
- 0.77
- Issuer
- PIMCO
- Inception Date
- Aug 31, 2017
- Dividend Yield
- 1.41%
- Asset Class
- Equity
- Index Tracked
- RAFI Dynamic Multi-Factor U.S. Index
MFUS Summary
MFUS is a U.S. stock market ETF that follows the RAFI Dynamic Multi-Factor U.S. Index, aiming to cover a wide range of American companies in many sectors like technology, health care, and energy. It uses a rules-based approach to pick stocks based on traits such as value and stability, rather than just size. Well-known holdings include Apple and Johnson & Johnson. Someone might invest in MFUS for broad diversification across the U.S. market with a tilt toward potentially higher-quality companies. A key risk is that it still moves up and down with the overall stock market, so your investment value can drop.
How much will it cost me?
MFUS has an expense ratio of 0.29%, which means you’ll pay about $2.90 per year for every $1,000 invested. This cost is a bit higher than the average index ETF because it’s a rules-based, multi-factor strategy that requires more specialized research and management than a simple passive market-cap index.
What would affect this ETF?
This ETF could benefit if the U.S. economy stays healthy, interest rates stabilize or fall, and large technology, health care, and energy companies like Apple, Johnson & Johnson, and Exxon Mobil continue to grow, since it is broadly invested across many U.S. sectors and uses a multi-factor approach that can adapt to different market conditions. On the other hand, a U.S. recession, rising interest rates, tighter regulations on big tech or health care, or a sharp drop in energy prices could hurt its major holdings and overall performance, especially given its strong focus on the U.S. market.
MFUS Top 10 Holdings
MFUS leans into U.S. blue chips, with Apple and Cisco giving the fund a tech-powered tailwind as both have been steadily rising this year. Health care is another key pillar: Eli Lilly and AbbVie have been climbing on strong drug pipelines, helping smooth out bumps elsewhere. Energy giants Exxon Mobil and Chevron are also pulling their weight, riding firm oil markets, while Walmart adds a defensive consumer edge with solid, if more modest, gains. Intel is the main laggard, showing mixed momentum that slightly tempers the otherwise broad-based, U.S.-focused strength.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 AAPL | Apple | 2.27% | $6.98M | $5.03T | 26.98% | 79Outperform |
 JNJ | Johnson & Johnson | 1.89% | $5.81M | $657.68B | 44.51% | 78Outperform |
 XOM | Exxon Mobil | 1.86% | $5.72M | $769.96B | 63.27% | 74Outperform |
 CVX | Chevron | 1.65% | $5.06M | $465.33B | 53.41% | 71Outperform |
 INTC | Intel | 1.54% | $4.73M | $347.61B | 63.75% | 64Neutral |
 LLY | Eli Lilly & Co | 1.66% | $5.10M | $1.33T | 67.86% | 72Outperform |
 ABBV | AbbVie | 1.47% | $4.54M | $521.11B | 29.22% | 66Neutral |
 WMT | Walmart | 1.44% | $4.43M | $979.90B | 20.82% | 78Outperform |
 CSCO | Cisco Systems | 1.18% | $3.62M | $411.45B | 43.34% | 77Outperform |
 BRK.B | Berkshire Hathaway B | 1.16% | $3.57M | $1.16T | 13.37% | 66Neutral |
MFUS Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For MFUS, the sentiment is Positive. The current price of 65.93 is above the 20-day moving average (MA) of 65.62, above the 50-day MA of 65.61, and above the 200-day MA of 63.02, indicating a bullish trend. The MACD of 0.16 indicates Negative momentum. The RSI at 53.51 is Neutral, neither overbought nor oversold. The STOCH value of 80.30 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for MFUS.
MFUS Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| MFUS | $65.93 | $72.00(9.21% Upside) | $307.92M | 0.29% | 71Outperform |
 HLAL | $71.52 | $91.44(27.85% Upside) | $972.36M | 0.50% | 76Outperform |
 SEUS | $25.65 | $30.86(20.30% Upside) | $946.37M | 0.30% | 73Outperform |
 AUSF | $51.89 | $57.31(10.44% Upside) | $902.41M | 0.27% | 71Outperform |
 BGDV | $31.27 | $37.25(19.11% Upside) | $877.55M | 0.45% | 74Outperform |
 AAUB | $49.94 | $60.70(21.54% Upside) | $845.51M | 0.10% | 66Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| MFUS | PIMCO RAFI Dynamic Multi-Factor U.S. Equity ETF | 65.93 | 11.18 | 20.43% | |
| HLAL | Wahed FTSE USA Shariah ETF | 71.52 | 10.37 | 16.96% | |
| SEUS | SEI QiM U.S. Equity Factor Allocation Active ETF | 25.65 | 0.39 | 1.53% | |
| AUSF | Global X Adaptive U.S. Factor ETF | 51.89 | 8.17 | 18.69% | |
| BGDV | Bahl & Gaynor Dividend ETF | 31.27 | 5.03 | 19.16% | |
| AAUB | Alpha Architect US Equity 4 ETF | 49.94 | 0.45 | 0.91% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.